Application of a Loading Dose of Colistin Methanesulfonate in Critically Ill Patients: Population Pharmacokinetics, Protein Binding, and Prediction of Bacterial Kill

↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Search: WFRF:(Karaiskos Ilias) > Application of a Lo...

5 of 5
Previous record
Next record
To hitlist

Application of a Loading Dose of Colistin Methanesulfonate in Critically Ill Patients : Population Pharmacokinetics, Protein Binding, and Prediction of Bacterial Kill

Mohamed, Ami Fazlin Syed (author): Uppsala universitet,Institutionen för farmaceutisk biovetenskap,Farmakometri

Karaiskos, Ilias (author)

Plachouras, Diamantis (author)

Karvanen, Matti (author): Uppsala universitet,Infektionssjukdomar

Pontikis, Konstantinos (author)

Jansson, Britt (author)

Papadomichelakis, Evangelos (author)

Antoniadou, Anastasia (author)

Giamarellou, Helen (author)

Armaganidis, Apostolos (author)

Cars, Otto (author): Uppsala universitet,Infektionssjukdomar

Friberg, Lena E. (author): Uppsala universitet,Institutionen för farmaceutisk biovetenskap,Farmakometri

show less...

(creator_code:org_t)

2012
2012
English.
In: Antimicrobial Agents and Chemotherapy. - 0066-4804 .- 1098-6596. ; 56:8, s. 4241-4249

Related links:: https://urn.kb.se/re...; show more...; https://doi.org/10.1...; show less...

Journal article (peer-reviewed)

Abstract Subject headings

A previous pharmacokinetic study on dosing of colistin methanesulfonate (CMS) at 240 mg (3 million units [MU]) every 8 h indicated that colistin has a long half-life, resulting in insufficient concentrations for the first 12 to 48 h after initiation of treatment. A loading dose would therefore be beneficial. The aim of this study was to evaluate CMS and colistin pharmacokinetics following a 480-mg (6-MU) loading dose in critically ill patients and to explore the bacterial kill following the use of different dosing regimens obtained by predictions from a pharmacokinetic-pharmacodynamic model developed from an in vitro study on Pseudomonas aeruginosa. The unbound fractions of colistin A and colistin B were determined using equilibrium dialysis and considered in the predictions. Ten critically ill patients (6 males; mean age, 54 years; mean creatinine clearance, 82 ml/min) with infections caused by multidrug-resistant Gram-negative bacteria were enrolled in the study. The pharmacokinetic data collected after the first and eighth doses were analyzed simultaneously with the data from the previous study (total, 28 patients) in the NONMEM program. For CMS, a two-compartment model best described the pharmacokinetics, and the half-lives of the two phases were estimated to be 0.026 and 2.2 h, respectively. For colistin, a one-compartment model was sufficient and the estimated half-life was 18.5 h. The unbound fractions of colistin in the patients were 26 to 41% at clinical concentrations. Colistin A, but not colistin B, had a concentration-dependent binding. The predictions suggested that the time to 3-log-unit bacterial kill for a 480-mg loading dose was reduced to half of that for the dose of 240 mg.

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

Antimicrobial Agents and Chemotherapy (Search for host publication in LIBRIS)

To the university's database

5 of 5
Previous record
Next record
To hitlist

Find more in SwePub

By the author/editor: Mohamed, Ami Faz ...; Karaiskos, Ilias; Plachouras, Diam ...; Karvanen, Matti; Pontikis, Konsta ...; Jansson, Britt; show more...; Papadomichelakis ...; Antoniadou, Anas ...; Giamarellou, Hel ...; Armaganidis, Apo ...; Cars, Otto; Friberg, Lena E.; show less...

Articles in the publication: Antimicrobial Ag ...

By the university: Uppsala University

Search outside SwePub

Extend your search to:: Google; Google Book Search; Google Scholar

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

LIBRIS.kb.se